Steroids Journal Citation Rate 2026
0039-128X
eISSN 1878-5867
Elsevier BV
US
Q2 Quartile Established Impact
About Steroids
Steroids (S) is a peer-reviewed academic journal covering Estrogen and related hormone effects and Hormonal Regulation and Hypertension, published by Elsevier BV in US, catalogued under ISSN 0039-128X (e-ISSN 1878-5867). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 2.29 (Q2 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model (APC ~$3500 USD). OpenAlex records 9,247 works and 215,169 citations, with an h-index of 152.
Steroids Citation Rate 2026 — In Context
Steroids has a 2025 2-Year Citation Rate (OpenAlex) of 2.29, placing it in the Q2 quartile within the Estrogen and related hormone effects research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
Steroids operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.
Researchers looking to publish in Steroids should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Steroids against similar journals in the field, use our journal comparison tool.
Submission Tips for Steroids
- Budget $3500 for the Article Processing Charge. Check if your institution or funder covers OA fees.
- This journal covers Estrogen and related hormone effects, Hormonal Regulation and Hypertension, Hormonal and reproductive studies. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Steroids Compares
Compared against 24 journals in the same research areas.
| ISSN (Print) | 0039-128X |
|---|---|
| ISSN (Online) | 1878-5867 |
| Publisher | Elsevier BV |
| Country | United States |
| APC / Cost | $3500 USD |
In-depth profile & metrics
Steroids is published by Elsevier BV and based in United States. It runs on a subscription or hybrid model with an article-processing charge of USD 3500.
In our subject taxonomy, Steroids is classified under Estrogen and related hormone effects, Hormonal Regulation and Hypertension, Hormonal and reproductive studies and Pharmacogenetics and Drug Metabolism.
Steroids is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.
Its most recent citation rate stands at 2.287.
Research Areas
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about Steroids
Live Indexing Status
Updated April 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 2.287 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Compare Journals
Compare Steroids against similar publications in its field:
Related Journals in Your Field
-
Clinical Science Portland Press IF 56.90
-
Archives of Toxicology Springer Science+Business Media IF 7.30
-
Breast Cancer Research BioMed Central IF 4.57
-
Chemico-Biological Interactions Elsevier BV IF 4.22
-
Journal of Personalized Medicine Multidisciplinary Digital Publishing Institute IF 3.90
Explore More Journals
Metadata
Last updated: Apr 24, 2026
Updated by: openalex_bulk
OpenAlex ID: S70286497
Get weekly updates for Estrogen and related hormone effects journals
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.